What is the current annual cash & cash equivalents of MRK?

As of today, MRK annual cash & cash equivalents is $14.69B

What is 1-year change in MRK annual cash & cash equivalents?

MRK annual cash & cash equivalents is up +6.72% year-over-year

What is 3-year change in MRK annual cash & cash equivalents?

MRK annual cash & cash equivalents is up +10.69% over the past 3 years

How far is MRK annual cash & cash equivalents from its all-time high?

MRK annual cash & cash equivalents is currently -15.99% below its historical high of $17.49B set on December 31, 2013

How does MRK annual cash & cash equivalents rank versus sector peers?

MRK annual cash & cash equivalents is higher than 99.65% of companies in Healthcare sector

When is MRK next annual earnings release?

The next annual earnings release for MRK is on February 2, 2027

What is the current quarterly cash & cash equivalents of MRK?

As of today, MRK quarterly cash & cash equivalents is $9.75B

What is MRK quarterly cash & cash equivalents most recent change?

MRK quarterly cash & cash equivalents was up +35.78% on September 30, 2026

What is 1-year change in MRK quarterly cash & cash equivalents?

MRK quarterly cash & cash equivalents is down -46.56% year-over-year

How far is MRK quarterly cash & cash equivalents from its all-time high?

MRK quarterly cash & cash equivalents is currently -56.18% below its historical high of $22.26B set on September 30, 2009

How does MRK quarterly cash & cash equivalents rank versus sector peers?

MRK quarterly cash & cash equivalents is higher than 99.10% of companies in Healthcare sector

When is MRK next earnings release?

The next earnings release for MRK is on February 2, 2027

MRK Cash & Equivalents History & Chart Since 1980

Annual Cash & Cash Equivalents

$14.69B$925.00M+6.72%

December 31, 2025

Summary

Current Value: As of today, MRK annual cash & cash equivalents is $14.69B, up +6.72% on December 31, 2025
Historical Performance: MRK annual cash & cash equivalents is up +10.69% over the past 3 years, up +82.48% over the past 5 years
All-Time High Comparison: MRK annual cash & cash equivalents is currently -15.99% below its historical high of $17.49B set on December 31, 2013
3-Year Low Comparison: MRK annual cash & cash equivalents is +105.14% above its 3-year low of $7.16B reached on December 31, 2023
Sector Comparison: MRK annual cash & cash equivalents is higher than 99.65% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

MRK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$14.69B	+6.7%	+10.7%	+82.5%	+20.4%
Quarterly Cash & Cash Equivalents	Sep 30, 26	$9.75B	-46.6%	+10.7%	-2.6%	-37.4%
Price	Nov 9, 26	$148.76	+72.4%	+45.3%	+79.8%	+361.4%
Annual Current Assets	Dec 31, 25	$43.52B	+12.2%	+21.8%	+56.7%	+49.7%
Annual Total Liabilities	Dec 31, 25	$84.20B	+19.0%	+33.4%	+27.2%	+71.9%
Annual Working Capital	Dec 31, 25	$15.19B	+46.6%	+32.3%	+3375.7%	+13.2%
Annual Net Income	Dec 31, 25	$18.26B	+6.6%	+25.7%	+303.8%	+1763.6%

Cash and Cash Equivalents Highs

MRK Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$14.69B	Dec 31, 25	at high
5Y	$14.69B	Dec 31, 25	at high
All	$17.49B	Dec 31, 13	-16.0%

Cash and Cash Equivalents Lows

MRK Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$7.16B	Dec 31, 23	+105.1%
5Y	$7.16B	Dec 31, 23	+105.1%
All	$226.61M	Dec 1, 81	+6382.6%

Cash and Cash Equivalents History

Year	Value	Change
2025	$14.69B	+6.7%
2024	$13.77B	+92.2%
2023	$7.16B	-46.0%
2022	$13.27B	+63.9%
2021	$8.10B	+0.6%
2020	$8.05B	-23.0%
2019	$10.45B	+17.9%
2018	$8.86B	+4.3%
2017	$8.50B	-40.7%
2016	$14.34B	+6.8%
2015	$13.43B	-14.6%
2014	$15.72B	-10.1%
2013	$17.49B	+8.3%
2012	$16.14B	+7.8%
2011	$14.97B	+22.7%
2010	$12.20B	+27.0%
2009	$9.60B	+75.1%
2008	$5.49B	-33.3%
2007	$8.23B	-5.5%
2006	$8.71B	-44.3%
2005	$15.64B	+120.6%
2004	$7.09B	+69.9%
2003	$4.17B	-16.1%

Year	Value	Change
2002	$4.97B	+51.3%
2001	$3.29B	-22.8%
2000	$4.25B	+32.9%
1999	$3.20B	-4.6%
1998	$3.36B	+45.3%
1997	$2.31B	+5.9%
1996	$2.18B	-34.9%
1995	$3.35B	+47.6%
1994	$2.27B	+47.2%
1993	$1.54B	+41.0%
1992	$1.09B	-22.5%
1991	$1.41B	+17.9%
1990	$1.20B	+4.7%
1989	$1.14B	-26.2%
1988	$1.55B	+35.0%
1987	$1.15B	+18.9%
1986	$965.80M	+14.7%
1985	$842.00M	+13.1%
1984	$744.32M	+100.8%
1983	$370.74M	+18.4%
1982	$313.24M	+38.2%
1981	$226.61M	-25.0%
1980	$302.27M	-

FAQ

What is the current annual cash & cash equivalents of MRK?: As of today, MRK annual cash & cash equivalents is $14.69B
What is 1-year change in MRK annual cash & cash equivalents?: MRK annual cash & cash equivalents is up +6.72% year-over-year
What is 3-year change in MRK annual cash & cash equivalents?: MRK annual cash & cash equivalents is up +10.69% over the past 3 years
How far is MRK annual cash & cash equivalents from its all-time high?: MRK annual cash & cash equivalents is currently -15.99% below its historical high of $17.49B set on December 31, 2013
How does MRK annual cash & cash equivalents rank versus sector peers?: MRK annual cash & cash equivalents is higher than 99.65% of companies in Healthcare sector
When is MRK next annual earnings release?: The next annual earnings release for MRK is on February 2, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$9.75B$2.57B+35.78%

September 30, 2026

Summary

Current Value: As of today, MRK quarterly cash & cash equivalents is $9.75B, up +35.78% on September 30, 2026
Historical Performance: MRK quarterly cash & cash equivalents is down -46.56% year-over-year, up +10.67% over the past 3 years
All-Time High Comparison: MRK quarterly cash & cash equivalents is currently -56.18% below its historical high of $22.26B set on September 30, 2009
3-Year Low Comparison: MRK quarterly cash & cash equivalents is +70.76% above its 3-year low of $5.71B reached on March 31, 2024
Sector Comparison: MRK quarterly cash & cash equivalents is higher than 99.10% of companies in Healthcare sector

Performance

MRK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Sep 30, 26	$9.75B	+35.8%	-46.6%	+10.7%	-2.6%
Annual Cash & Cash Equivalents	Dec 31, 25	$14.69B	–	+6.7%	+10.7%	+82.5%
Price	Nov 9, 26	$148.76	+15.7%	+72.4%	+45.3%	+79.8%
Quarterly Current Assets	Sep 30, 26	$38.94B	+6.2%	-18.1%	+21.9%	+25.4%
Quarterly Total Liabilities	Sep 30, 26	$87.83B	+0.0%	+13.1%	+34.2%	+52.4%
Quarterly Working Capital	Sep 30, 26	$10.14B	+13.3%	-46.4%	+14.4%	+38.3%
Quarterly Net Income	Sep 30, 26	$5.07B	+479.0%	-12.4%	+6.7%	+10.8%

Quarterly Cash & Cash Equivalents Highs

MRK Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$18.25B	N/A	-46.6%
3Y	$18.25B	Sep 30, 25	-46.6%
5Y	$18.25B	Sep 30, 25	-46.6%
All	$22.26B	Sep 30, 09	-56.2%

Quarterly Cash & Cash Equivalents Lows

MRK Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$5.77B	Mar 31, 26	+68.9%
3Y	$5.71B	Mar 31, 24	+70.8%
5Y	$5.71B	Mar 31, 24	+70.8%
All	$508.70M	Mar 31, 90	+1817.0%

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Sep 2026	$9.75B	+35.8%
Jun 2026	$7.18B	+24.4%
Mar 2026	$5.77B	-60.7%
Dec 2025	$14.69B	-19.5%
Sep 2025	$18.25B	+110.6%
Jun 2025	$8.67B	-7.1%
Mar 2025	$9.33B	-32.2%
Dec 2024	$13.77B	-5.9%
Sep 2024	$14.64B	+28.4%
Jun 2024	$11.40B	+99.5%
Mar 2024	$5.71B	-20.2%
Dec 2023	$7.16B	-18.7%
Sep 2023	$8.81B	+37.2%
Jun 2023	$6.42B	-38.4%
Mar 2023	$10.42B	-21.5%
Dec 2022	$13.27B	+16.6%
Sep 2022	$11.38B	+11.5%
Jun 2022	$10.21B	+13.6%
Mar 2022	$8.99B	+11.0%
Dec 2021	$8.10B	-19.2%
Sep 2021	$10.02B	+16.8%
Jun 2021	$8.58B	+22.8%
Mar 2021	$6.98B	-13.3%
Dec 2020	$8.05B	+9.4%
Sep 2020	$7.36B	-33.7%
Jun 2020	$11.10B	+49.4%
Mar 2020	$7.43B	-28.9%
Dec 2019	$10.45B	+30.3%
Sep 2019	$8.02B	+12.9%
Jun 2019	$7.11B	-19.2%
Mar 2019	$8.80B	-0.7%
Dec 2018	$8.86B	-13.8%
Sep 2018	$10.29B	+35.4%
Jun 2018	$7.59B	+3.4%
Mar 2018	$7.35B	-13.6%
Dec 2017	$8.50B	-24.1%
Sep 2017	$11.20B	-6.5%
Jun 2017	$11.97B	-21.5%
Mar 2017	$15.25B	+6.3%
Dec 2016	$14.34B	+9.7%
Sep 2016	$13.07B	+10.4%
Jun 2016	$11.83B	-8.6%
Mar 2016	$12.94B	-3.6%
Dec 2015	$13.43B	+11.1%
Sep 2015	$12.09B	+6.3%
Jun 2015	$11.37B	-27.1%
Mar 2015	$15.60B	-0.8%
Dec 2014	$15.72B	+9.6%
Sep 2014	$14.35B	+7.1%
Jun 2014	$13.40B	-34.7%
Mar 2014	$20.51B	+17.3%
Dec 2013	$17.49B	-3.8%
Sep 2013	$18.17B	+0.4%
Jun 2013	$18.10B	+13.0%
Mar 2013	$16.02B	-0.7%
Dec 2012	$16.14B	-10.9%
Sep 2012	$18.12B	+3.8%
Jun 2012	$17.45B	+12.1%
Mar 2012	$15.57B	+4.0%
Dec 2011	$14.97B	-3.9%
Sep 2011	$15.58B	+11.4%
Jun 2011	$13.98B	+7.3%
Mar 2011	$13.03B	+6.8%
Dec 2010	$12.20B	+14.8%
Sep 2010	$10.62B	+6.9%
Jun 2010	$9.94B	+1.7%

Month	Value	Change
Mar 2010	$9.78B	+1.8%
Dec 2009	$9.60B	-56.8%
Sep 2009	$22.26B	+31.4%
Jun 2009	$16.93B	+34.6%
Mar 2009	$12.58B	+129.3%
Dec 2008	$5.49B	-19.8%
Sep 2008	$6.84B	-31.5%
Jun 2008	$9.99B	+9.0%
Mar 2008	$9.16B	+11.3%
Dec 2007	$8.23B	+11.4%
Sep 2007	$7.39B	+34.3%
Jun 2007	$5.50B	+35.7%
Mar 2007	$4.06B	-53.4%
Dec 2006	$8.71B	-4.1%
Sep 2006	$9.09B	-13.2%
Jun 2006	$10.46B	-15.6%
Mar 2006	$12.40B	-20.7%
Dec 2005	$15.64B	+11.5%
Sep 2005	$14.03B	+7.7%
Jun 2005	$13.03B	+38.1%
Mar 2005	$9.44B	+149.7%
Sep 1999	$3.78B	+6.7%
Jun 1999	$3.54B	+14.4%
Mar 1999	$3.10B	-22.9%
Sep 1998	$4.01B	+42.9%
Mar 1998	$2.81B	+149.7%
Dec 1997	$1.13B	-12.2%
Sep 1997	$1.28B	-19.2%
Jun 1997	$1.59B	-8.6%
Mar 1997	$1.74B	+28.4%
Dec 1996	$1.35B	+0.6%
Sep 1996	$1.34B	-20.3%
Jun 1996	$1.69B	-3.8%
Mar 1996	$1.75B	-5.1%
Dec 1995	$1.85B	-3.1%
Sep 1995	$1.91B	+14.5%
Jun 1995	$1.66B	-25.1%
Mar 1995	$2.22B	+38.5%
Dec 1994	$1.60B	+32.2%
Sep 1994	$1.21B	-0.5%
Jun 1994	$1.22B	+33.0%
Mar 1994	$917.00M	+10.6%
Dec 1993	$829.40M	-30.7%
Sep 1993	$1.20B	+41.2%
Jun 1993	$847.80M	+20.7%
Mar 1993	$702.50M	+22.2%
Dec 1992	$575.10M	-33.8%
Sep 1992	$868.80M	+21.4%
Jun 1992	$715.90M	+3.0%
Mar 1992	$694.80M	-12.9%
Dec 1991	$797.90M	-13.3%
Sep 1991	$920.30M	+28.1%
Jun 1991	$718.20M	-7.8%
Mar 1991	$779.20M	-3.4%
Dec 1990	$806.40M	+24.5%
Sep 1990	$647.60M	+15.5%
Jun 1990	$560.80M	+10.2%
Mar 1990	$508.70M	-25.7%
Dec 1989	$685.10M	+9.8%
Sep 1989	$623.80M	-59.8%
Dec 1988	$1.55B	+35.0%
Dec 1987	$1.15B	+18.9%
Dec 1986	$965.80M	+14.7%
Dec 1985	$842.00M	+13.1%
Dec 1984	$744.30M	-

FAQ

What is the current quarterly cash & cash equivalents of MRK?: As of today, MRK quarterly cash & cash equivalents is $9.75B
What is MRK quarterly cash & cash equivalents most recent change?: MRK quarterly cash & cash equivalents was up +35.78% on September 30, 2026
What is 1-year change in MRK quarterly cash & cash equivalents?: MRK quarterly cash & cash equivalents is down -46.56% year-over-year
How far is MRK quarterly cash & cash equivalents from its all-time high?: MRK quarterly cash & cash equivalents is currently -56.18% below its historical high of $22.26B set on September 30, 2009
How does MRK quarterly cash & cash equivalents rank versus sector peers?: MRK quarterly cash & cash equivalents is higher than 99.10% of companies in Healthcare sector
When is MRK next earnings release?: The next earnings release for MRK is on February 2, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

MRK Official Website www.merck.com
MRK Profile on Yahoo Finance finance.yahoo.com/quote/MRK
MRK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrk